Citation Impact
Citing Papers
FLT3 inhibitors in acute myeloid leukemia
2018
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Top 10 Challenges in Cancer Immunotherapy
2020
Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy
2020
Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation
2012
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
The past and future of CD33 as therapeutic target in acute myeloid leukemia
2014
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Cancer stem cells revisited
2017 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment
2015
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Mechanisms and applications of the anti-inflammatory effects of photobiomodulation
2017 Standout
Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion
2018
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
2017
Bispecific antibodies: a mechanistic review of the pipeline
2019
Investigational CD33-targeted therapeutics for acute myeloid leukemia
2018
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
Modular repeat protein sculpting using rigid helical junctions
2020 StandoutNobel
Signaling and cytotoxic functions of 4-hydroxyalkenals
2010
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Works of Thomas Köhnke being referenced
Recent developments in immunotherapy of acute myeloid leukemia
2017
Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab
2015
Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis
2008
Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
2015
Immunotherapy for Acute Myeloid Leukemia
2015
Single-cell mutational profiling enhances the clinical evaluation of AML MRD
2020
CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell–engaging antibody AMG 330
2013